Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy

Carlos A. Castañeda, Elizabeth A. Mittendorf, Sandro Casavilca‐Zambrano, Yun Wu, Miluska Castillo, Patricia Arboleda, Teresa Nunez, Carlos Barrionuevo, Ketty Dolores-Cerna, Carolina Belmar-López,

World Journal of Clinical Oncology · 2016 · 60 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

AIM: To determine influence of neoadjuvant-chemotherapy (NAC) over tumor-infiltrating-lymphocytes (TIL) in triple-negative-breast-cancer (TNBC). METHODS: value < 0.05 was considered statistically significant. RESULTS: < 0.0001). Percentage of TIL subpopulations was correlated with their absolute counts. Higher counts of CD3, CD4, CD8 and FOXP3 in pre-NAC samples had longer disease-free-survival (DFS). Higher counts of CD3 in pre-NAC samples had longer overall-survival. Higher ratio of CD8/CD4 counts in pre-NAC was associated with pCR. Higher ratio of CD4/FOXP3 counts in pre-NAC was associated with longer DFS. Higher counts of CD4 in post-NAC samples were associated with pCR. CONCLUSION: TIL in pre-NAC full-face sections in TNBC are correlated to longer survival. TIL in full-face differ from TMA sections, absolute count and percentage analysis of TIL subpopulation closely related.

References

22